Actively Recruiting
Fexofenadine as Adjuvant Therapy in Parkinson Disease
Led by Tanta University · Updated on 2026-01-21
46
Participants Needed
1
Research Sites
105 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Parkinson's disease (PD) is a chronic, progressive neurological disorder characterized by both motor and non-motor symptoms. PD is the second most common neurodegenerative disorder after Alzheimer's disease and the most common movement disorder. PD has age-related pathology; it is present in 1-2% of the population over 60 years of age. The disease is characterized by a triad of disordered voluntary motor activity in the form of bradykinesia (slowness of movement) or even akinesia (absence of movement),rigidity and postural instability, and a resting tremor of the hands and less commonly the feet.
CONDITIONS
Official Title
Fexofenadine as Adjuvant Therapy in Parkinson Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 50 years or older
- Male or female participants
- Diagnosed with Parkinson's disease
- Currently receiving dopamine replacement therapy
- Modified Hoehn and Yahr stage 1 to 4
You will not qualify if you...
- Atypical parkinsonism or drug-induced parkinsonism
- Breastfeeding women
- Pregnant women or women planning pregnancy
- Significant liver or kidney function problems
- History or presence of acute heart disease
- Alcohol or drug abuse
- Known allergy to study medications
- Other medical conditions that may interfere with results or pose risk to the participant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tanta University
Tanta, Egypt, 31511
Actively Recruiting
Research Team
I
Ihab Elsayed Hassan, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here